Greenfield Savings Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$752K Sell
31,225
-1,906
-6% -$49.9K 0.29% 85
2026
Q1
$930K Sell
33,131
-1,510
-4% -$40.2K 0.4% 63
2025
Q4
$863K Sell
34,641
-894
-3% -$22.5K 0.36% 71
2025
Q3
$905K Sell
35,535
-730
-2% -$18K 0.38% 69
2025
Q2
$879K Sell
36,265
-1,068
-3% -$24.9K 0.4% 67
2025
Q1
$946K Buy
37,333
+1,451
+4% +$38K 0.46% 61
2024
Q4
$952K Sell
35,882
-2,867
-7% -$77.8K 0.46% 59
2024
Q3
$1.12M Sell
38,749
-2,907
-7% -$84.8K 0.53% 57
2024
Q2
$1.17M Sell
41,656
-1,435
-3% -$39.5K 0.6% 49
2024
Q1
$1.2M Buy
43,091
+568
+1% +$15.8K 0.63% 47
2023
Q4
$1.22M Sell
42,523
-611
-1% -$18.5K 0.71% 45
2023
Q3
$1.43M Sell
43,134
-2,664
-6% -$94.2K 0.9% 34
2023
Q2
$1.68M Buy
45,798
+1,195
+3% +$46.5K 1.14% 24
2023
Q1
$1.82M Buy
44,603
+603
+1% +$26K 1.18% 24
2022
Q4
$2.25M Sell
44,000
-414
-0.9% -$19.8K 1.49% 17
2022
Q3
$1.94M Sell
44,414
-442
-1% -$21.5K 1.4% 18
2022
Q2
$2.35M Buy
+44,856
New +$2.29M 1.58% 17

Other funds holding PFE

Greenfield Savings Bank's PFE Position: Q2 2026 in Review

Greenfield Savings Bank reduced its Pfizer (PFE) stake by 5.8% in Q2 2026, selling an estimated $49.9K and leaving 31,225 shares worth $752K. The position accounts for 0.29% of the portfolio, ranked #85.

Greenfield Savings Bank first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.35M in Q2 2022. 1,484 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Greenfield Savings Bank held 31,225 shares of Pfizer worth $752K as of Q2 2026.
  • Greenfield Savings Bank sold 1,906 Pfizer shares in Q2 2026, an estimated $49.9K.
  • Pfizer made up 0.29% of Greenfield Savings Bank's portfolio in Q2 2026, its #85 holding.
  • Greenfield Savings Bank first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Greenfield Savings Bank's Pfizer position peaked at $2.35M in Q2 2022.
  • 1,484 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Greenfield Savings Bank's 13F filing for Q2 2026, filed 7 Jul 2026.